Global Microbiology Diagnostic Devices And Equipment Market Size 2024, Forecast To 2033
11 Mar, 2024
The market for microbiology diagnostic devices and equipment has experienced rapid growth, surging from $4.49 billion in 2023 to $5.02 billion in 2024, reflecting a compound annual growth rate (CAGR) of 11.8%. This growth in the historic period is attributed to increased healthcare expenditure, the expansion of emerging markets, rapid technological advances, a surge in the aging population, and the emergence of novel pathogenic infestations. Moving forward to 2028, the market is expected to continue its rapid growth, projected to reach $7.74 billion at a slightly decreased CAGR of 11.4%. Drivers of this growth include a rise in funding, the aging population, increased healthcare access, and a rapid increase in various bacterial and viral epidemics. Noteworthy trends in the forecast period encompass the growing adoption of predictive diagnostics, automation in the field of microbiology diagnostics, next-generation microbial testing, and an increase in mergers and acquisitions.
Global Microbiology Diagnostic Devices And Equipment Market Key Driver
Increasing funding of public and private investments in medical devices is driving the growth of the microbiology diagnostic devices market. Increasing Investments indicate the rising confidence of various private and public players on microbiology diagnostic devices, thereby indicating a progressive increase and stimulating growth. For instance, according to MedTech news, a publisher of new related to medical technology, private equity industry invested $111.8 B (c.$ 151 B) in healthTech industry. Furthermore, globally 96 deals valued at $40.8 billion were completed in medTech vertical. The increasing investments in digital health technologies, artificial intelligence and non-invasive monitoring capability, delivery of gene therapy and regenerative medicines technologies, and customized 3D printing of medical devices are expected to drive the microbiology diagnostic devices market. In 2023, this financial backing is evident, and by 2024, the market continues to benefit from substantial investments. Looking ahead to 2028, the market size is projected to reflect sustained growth, driven by ongoing confidence and funding in microbiology diagnostic devices.
Get A Free Sample Of The Global Microbiology Diagnostic Devices And Equipment Market ReportGlobal Microbiology Diagnostic Devices And Equipment Market Segments
The microbiology diagnostic devices and equipment market covered in this report is segmented –
1) By Type: Laboratory Instruments, Microbiology Analyzers, Reagents And Consumables
2) By Reagents: Pathogen-Specific Kits, General Reagents
3) By End-User: Diagnostic Laboratories, Hospitals, Other End-Users
Sub segments: Incubators, Gram Strainers, Bacterial Colony Counters, Petri Dish Fillers, Automated Culture Systems, Other Laboratory Instruments, Microscopes, Mass Spectrometers, Other Microbiology Analyzers, Oncology, Hormonal Disorder, Glaucoma, Other Therapeutic Applications
By Geography:The regions covered in the microbiology diagnostic devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
North America was the largest region in the microbiology diagnostics devices and equipment market in 2023. Asia-Pacific was the second largest region in the global microbiology diagnostic devices and equipment market. The regions covered in the microbiology diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Microbiology Diagnostic Devices And Equipment Industry Players
Danaher, Abbott Laboratories, Thermo Fisher Scientific, Becton Dickinson and Company, Biomerieux, Bio-Rad Laboratories Inc., Roche, Bruker Corporation, Charles River Laboratories International Inc., Merck KGaA, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc., Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers, TestLine Clinical Diagnostics s.r.o., Cepheid, Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Qiagen N.V., Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc., PerkinElmer, Inc., Adavium Medical, DK Diagnostics, Crosmed, Ortopedia Alemana, Simed, Shalina Healthcare, Elixir Medical Equipment LLC (EME), Matrix Medical, Gulf Medical Co, Almarfa Medical, Lithotech Medical, Neogen Corporation
Get The Full Global Microbiology Diagnostic Devices And Equipment Market Report
Microbiology Diagnostic Devices And Equipment Market Overview
Microbiology diagnostics devices and equipment are a broad category covering all kinds of items used in microbiology laboratories and used to diagnose infectious diseases by examining pathogens. These devices and equipment included microscopes, slides, test tubes, Petri dishes, growth media (liquid and solid), inoculation loops, pipettes, and tips, incubators, autoclaves, and laminar flow hoods. Some pieces of equipment are permanent, like microscopes and hoods, while others are not, like pipette tips.
Microbiology Diagnostic Devices And Equipment Global Market Report 2023 provides data on the global microbiology diagnostic devices and equipment market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The microbiology diagnostic devices and equipment market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.